All In Biotech

Drug Trial Radar · NCT07209332

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

An Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, Pharmacokinetics, and Efficacy of WVE-N531 in Patients With Duchenne Muscular Dystrophy Who Participated in Another Study of WVE-N531

Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

175

Planned (sponsor's estimate)

Start

Dec 28, 2025

Primary completion

Mar 2029

Study completion Mar 2029

Sponsor

Lead sponsor
Wave Life Sciences USA, Inc.Industry
Sponsor type
Industry
First posted
Oct 7, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2 open-label extension (OLE) study to evaluate the long-term safety, tolerability, efficacy, pharmacokinetics, and the pharmacodynamics (PD) through potential exploratory biomarker(s) of intravenous (IV) WVE-N531 in patients with DMD who participated in another study of WVE-N531. All patients will have rolled over from a previous study of WVE-N531.

Conditions

  • Duchenne Muscular Dystrophy

Interventions

  • WVE-N531Drug

    WVE-N531 is an antisense oligonucleotide (ASO)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with treatment related adverse events as assessed by the following parameters:Time frame: Time Frame: Week 0 through Week 96

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Istiklal Hospital/ Clinical Research Unit

    Amman, Jordan

  • The Specialty Hospital (TSH)/ Advanced Clinical Center

    Amman, Jordan

  • Oxford Children's Hospital, Oxford University Hospitals NHS Foundation Trust

    Headington, Oxford, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.